Pharmaceutical companies have more reasons than ever to hone their launch readiness skills. The question is whether they possess the new product launch strategies and tools to successfully commercialise their new medicines in an often volatile and always competitive global marketplace.
Access to medicines is a loaded term. In an ideal world, every patient would have unimpeded access to the best drug available. In reality, access is usually selective at best.